From Blisters to Bliss: A New Horizon in Bullous Pemphigoid Treatment: An Online Activity

This 20-minute Seminar in Depth from the 2025 Winter Clinical Miami and Hawaii conferences features a discussion of the pathophysiology of bullous pemphigoid and the management of clinical cases using safety and efficacy data for emerging targeted therapies.

“We see these patients and it seems like it’s (treatment’s) going to be easy but, unfortunately, it’s a lot for these patients to handle. And so, really, when we’re thinking about the holy grail, the ideal treatment that we’d be looking for, it would be something that works quickly to minimize prednisone, no lab work monitoring, very safe, and very effective.” - Dr. Donna Culton

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals, Inc.